• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接种减毒活甲型流感(H5N2)疫苗的健康年轻成年人的记忆性T细胞免疫反应。

Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine.

作者信息

Chirkova T V, Naykhin A N, Petukhova G D, Korenkov D A, Donina S A, Mironov A N, Rudenko L G

机构信息

Department of Virology, Institute of Experimental Medicine, Acad. Pavlov St. 12, Saint Petersburg 197376, Russia.

出版信息

Clin Vaccine Immunol. 2011 Oct;18(10):1710-8. doi: 10.1128/CVI.05116-11. Epub 2011 Aug 3.

DOI:10.1128/CVI.05116-11
PMID:21813657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3187019/
Abstract

Cellular immune responses of both CD4 and CD8 memory/effector T cells were evaluated in healthy young adults who received two doses of live attenuated influenza A (H5N2) vaccine. The vaccine was developed by reassortment of nonpathogenic avian A/Duck/Potsdam/1402-6/68 (H5N2) and cold-adapted A/Leningrad/134/17/57 (H2N2) viruses. T-cell responses were measured by standard methods of intracellular cytokine staining of gamma interferon (IFN-γ)-producing cells and a novel T-cell recognition of antigen-presenting cells by protein capture (TRAP) assay based on the trogocytosis phenomenon, namely, plasma membrane exchange between interacting immune cells. TRAP enables the detection of activated trogocytosis-positive T cells after virus stimulation. We showed that two doses of live attenuated influenza A (H5N2) vaccine promoted both CD4 and CD8 T-memory-cell responses in peripheral blood of healthy young subjects in the clinical study. Significant differences in geometric mean titers (GMTs) of influenza A (H5N2)-specific IFN-γ(+) cells were observed at day 42 following the second vaccination, while peak levels of trogocytosis(+) T cells were detected earlier, on the 21st day after the second vaccination. The inverse correlation of baseline levels compared to postvaccine fold changes in GMTs of influenza-specific CD4 and CD8 T cells demonstrated that baseline levels of these specific cells could be considered a predictive factor of vaccine immunogenicity.

摘要

在接种两剂甲型流感(H5N2)减毒活疫苗的健康年轻成年人中评估了CD4和CD8记忆/效应T细胞的细胞免疫反应。该疫苗是通过将非致病性禽源A/鸭/波茨坦/1402-6/68(H5N2)病毒与冷适应的A/列宁格勒/134/17/57(H2N2)病毒重配而研发的。通过检测产生γ干扰素(IFN-γ)细胞的细胞内细胞因子染色的标准方法以及基于胞啃现象(即相互作用的免疫细胞之间的质膜交换)的蛋白质捕获(TRAP)测定法来测量T细胞反应,TRAP可检测病毒刺激后活化的胞啃阳性T细胞。我们发现在临床研究中,两剂甲型流感(H5N2)减毒活疫苗促进了健康年轻受试者外周血中CD4和CD8 T记忆细胞反应。在第二次接种后第42天观察到甲型流感(H5N2)特异性IFN-γ(+)细胞的几何平均滴度(GMT)有显著差异,而胞啃(+) T细胞的峰值水平在第二次接种后第21天更早被检测到。与流感特异性CD4和CD8 T细胞的疫苗后GMT倍数变化相比,基线水平呈负相关,这表明这些特异性细胞的基线水平可被视为疫苗免疫原性的预测因素。

相似文献

1
Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine.接种减毒活甲型流感(H5N2)疫苗的健康年轻成年人的记忆性T细胞免疫反应。
Clin Vaccine Immunol. 2011 Oct;18(10):1710-8. doi: 10.1128/CVI.05116-11. Epub 2011 Aug 3.
2
Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).减毒活流感重组H5疫苗的安全性和免疫原性(I-II期临床试验)
Influenza Other Respir Viruses. 2008 Nov;2(6):203-9. doi: 10.1111/j.1750-2659.2008.00064.x.
3
[Evaluation of the anti-neuraminidase antibodies in clinical trials of the live influenza vaccine of the A(H5N2) subtype].[A(H5N2)亚型流感活疫苗临床试验中抗神经氨酸酶抗体的评估]
Vopr Virusol. 2013 Nov-Dec;58(6):31-5.
4
[Stimulation of homo- and heterologic T-cell immunological memory in volunteers inoculated with live influenza A (H5N2) reassortant vaccine].[接种甲型流感(H5N2)重组活疫苗的志愿者体内同源和异源T细胞免疫记忆的刺激]
Vopr Virusol. 2012 Jan-Feb;57(1):38-42.
5
Cross- immunity of a H9N2 live attenuated influenza vaccine against H5N2 highly pathogenic avian influenza virus in chickens.H9N2 活疫苗对鸡 H5N2 高致病性禽流感病毒的交叉免疫性。
Vet Microbiol. 2018 Jul;220:57-66. doi: 10.1016/j.vetmic.2018.05.005. Epub 2018 May 21.
6
[Results of clinical trials on reactogenicity, safety, and immunogenicity of influenza allantoic intranasal live vaccine "Ultragrivac" (type A/H5N2)].["甲型/ H5N2流感尿囊内鼻用活疫苗“Ultragrivac”的反应原性、安全性及免疫原性临床试验结果"]
Vestn Ross Akad Med Nauk. 2010(3):15-20.
7
Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.潜在大流行流感病毒活减毒疫苗的遗传稳定性。
Vaccine. 2015 Dec 8;33(49):7008-14. doi: 10.1016/j.vaccine.2015.09.050. Epub 2015 Oct 2.
8
B- and T-cell memory elicited by a seasonal live attenuated reassortant influenza vaccine: assessment of local antibody avidity and virus-specific memory T-cells using trogocytosis-based method.基于细胞融合的方法评估季节性流感减毒活疫苗诱导的 B 细胞和 T 细胞记忆:局部抗体亲和性和病毒特异性记忆 T 细胞的评估。
Influenza Other Respir Viruses. 2012 Mar;6(2):119-26. doi: 10.1111/j.1750-2659.2011.00279.x. Epub 2011 Aug 8.
9
[Estimation of human and animal immunological memory by testing the trogocytosis of virus-specific T lymphocytes].[通过检测病毒特异性T淋巴细胞的噬细胞作用评估人和动物的免疫记忆]
Vopr Virusol. 2011 Sep-Oct;56(5):15-21.
10
[The inoculative properties of cold-adapted reassortant A(H5N2) influenza strain during intranasal administration to mice].[冷适应重配A(H5N2)流感病毒株经鼻内接种小鼠的接种特性]
Vopr Virusol. 2007 Jul-Aug;52(4):27-30.

引用本文的文献

1
Lymphocytes and Trogocytosis-Mediated Signaling.淋巴细胞与细胞吞噬作用介导的信号转导。
Cells. 2021 Jun 12;10(6):1478. doi: 10.3390/cells10061478.
2
Avian influenza A (H7N9) virus: from low pathogenic to highly pathogenic.禽流感病毒 A(H7N9):从低致病性到高致病性。
Front Med. 2021 Aug;15(4):507-527. doi: 10.1007/s11684-020-0814-5. Epub 2021 Apr 16.
3
Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge.用通用减毒活流感疫苗候选株进行序贯免疫可保护雪貂免受高剂量异源病毒攻击。
Vaccines (Basel). 2019 Jul 8;7(3):61. doi: 10.3390/vaccines7030061.
4
Live Attenuated Reassortant Vaccines Based on A/Leningrad/134/17/57 Master Donor Virus Against H5 Avian Influenza.基于A/列宁格勒/134/17/57主供体病毒的H5禽流感减毒活重配疫苗
Open Microbiol J. 2017 Nov 30;11:316-329. doi: 10.2174/1874285801711010316. eCollection 2017.
5
Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial.一种减毒活流感H5候选疫苗株A/17/火鸡/土耳其/05/133 H5N2的安全性和免疫原性及其对潜在大流行前使用的启动作用:一项随机、双盲、安慰剂对照试验。
Lancet Infect Dis. 2017 Aug;17(8):833-842. doi: 10.1016/S1473-3099(17)30240-2. Epub 2017 May 19.
6
Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination.减毒活流感疫苗接种后儿童体内交叉反应性及与保护相关的T细胞的增强
J Infect Dis. 2017 May 15;215(10):1527-1535. doi: 10.1093/infdis/jix165.
7
H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets.H7N9 减毒活流感疫苗具有高度免疫原性,可防止病毒复制,并保护雪貂免受严重支气管肺炎的侵害。
Mol Ther. 2016 May;24(5):991-1002. doi: 10.1038/mt.2016.23. Epub 2016 Jan 22.
8
Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine.对先前接种过H5N2减毒活流感疫苗的个体进行H5N1灭活流感疫苗免疫反应评估。
Hum Vaccin Immunother. 2015;11(12):2839-48. doi: 10.1080/21645515.2015.1069931.
9
Interferon-Gamma Release Assay: An Effective Tool to Detect Early Toxoplasma gondii Infection in Mice.干扰素-γ释放试验:检测小鼠早期弓形虫感染的有效工具。
PLoS One. 2015 Sep 17;10(9):e0137808. doi: 10.1371/journal.pone.0137808. eCollection 2015.
10
Antiviral B cell and T cell immunity in the lungs.肺部的抗病毒B细胞和T细胞免疫。
Nat Immunol. 2015 Jan;16(1):18-26. doi: 10.1038/ni.3056.

本文引用的文献

1
Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine.一种复制缺陷型鼻内DeltaNS1 H5N1流感疫苗的临床前评估。
PLoS One. 2009 Jun 19;4(6):e5984. doi: 10.1371/journal.pone.0005984.
2
Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).减毒活流感重组H5疫苗的安全性和免疫原性(I-II期临床试验)
Influenza Other Respir Viruses. 2008 Nov;2(6):203-9. doi: 10.1111/j.1750-2659.2008.00064.x.
3
Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates.一种减毒活H5N1疫苗在非人灵长类动物中的免疫原性和保护效力
PLoS Pathog. 2009 May;5(5):e1000409. doi: 10.1371/journal.ppat.1000409. Epub 2009 May 1.
4
Report of the 5th meeting on the evaluation of pandemic influenza prototype vaccines in clinical trials: World Health Organization, Geneva, Switzerland, 12-13 February 2009.关于大流行性流感原型疫苗临床试验评估的第五次会议报告:2009年2月12日至13日于瑞士日内瓦世界卫生组织召开
Vaccine. 2009 Jun 24;27(31):4079-89. doi: 10.1016/j.vaccine.2009.04.059. Epub 2009 May 9.
5
Binding of rituximab, trastuzumab, cetuximab, or mAb T101 to cancer cells promotes trogocytosis mediated by THP-1 cells and monocytes.利妥昔单抗、曲妥珠单抗、西妥昔单抗或单克隆抗体T101与癌细胞的结合可促进由THP-1细胞和单核细胞介导的肿瘤细胞吞噬作用。
J Immunol. 2008 Dec 1;181(11):8120-32. doi: 10.4049/jimmunol.181.11.8120.
6
Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals.由季节性甲型人流感感染所建立的记忆T细胞在健康个体中与甲型禽流感(H5N1)发生交叉反应。
J Clin Invest. 2008 Oct;118(10):3478-90. doi: 10.1172/JCI32460.
7
Baseline levels of influenza-specific CD4 memory T-cells affect T-cell responses to influenza vaccines.流感特异性CD4记忆T细胞的基线水平会影响T细胞对流感疫苗的反应。
PLoS One. 2008 Jul 2;3(7):e2574. doi: 10.1371/journal.pone.0002574.
8
Report of the 4th meeting on the "Evaluation of pandemic influenza prototype vaccines in clinical trials." World Health Organization, Geneva, Switzerland, 14-15 February 2008.“大流行性流感原型疫苗临床试验评估”第四次会议报告。世界卫生组织,瑞士日内瓦,2008年2月14 - 15日。
Vaccine. 2008 Sep 15;26(39):4975-7. doi: 10.1016/j.vaccine.2008.04.050. Epub 2008 May 9.
9
Human infection with highly pathogenic H5N1 influenza virus.人类感染高致病性H5N1流感病毒。
Lancet. 2008 Apr 26;371(9622):1464-75. doi: 10.1016/S0140-6736(08)60627-3.
10
Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China.中国高致病性甲型禽流感病毒(H5N1)可能存在有限的人传人情况。
Lancet. 2008 Apr 26;371(9622):1427-34. doi: 10.1016/S0140-6736(08)60493-6. Epub 2008 Apr 8.